Sandu Pharmaceuticals Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on February 14, 2017, to approve Unaudited Financials of the Company for the Quarter Ended December 31, 2016. In Compliance with the Company’s Code of Conduct for prevention of Insider Trading devised as per the SEBI (Prohibition of Insider Trading) Regulations, 1992, amended till date, Company further inform that the trading window for dealing in the Securities of the Company shall be closed for the Company’s Directors/Officer and designated employees of the Company from the opening of Trading hours on February 04, 2017 till 48 hours after announcement of financial results to public in compliances with the code of conduct for prevention of Insider.
Pdf Link:Board Meeting Intimation for Results & Closure of Trading Window
Source : BSE - www.bseindia.com
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.